UiPath is rising today: what traders are watching (January 6)

Traders Union
All News
Financial News
UiPath Surges 8.11% Today

Highlights

UiPath joined the S&P MidCap 400 index, replacing Synovus Financial Corp., signaling increased investor visibility and benchmark inclusion.
The company reported third-quarter revenue of $411 million, exceeding analyst estimates, with annual revenues surpassing $1.42 billion.
UiPath's CFO, CEO, and Chief Accounting Officer executed notable share sales, while the company was recognized as a leader in autonomous testing platforms and announced new AI-driven service integrations.

Revenue beat and index inclusion drive sentiment amid insider selling

UiPath recently joined the S&P MidCap 400 index, replacing Synovus Financial Corp. The company reported strong financial results, including third-quarter revenue of $411 million that exceeded analyst estimates and annual revenues above $1.42 billion. Leadership activity included notable share sales by the CFO, CEO, and Chief Accounting Officer, while UiPath was also recognized as a leader in autonomous testing platforms and announced new AI-driven service integrations.

Anton Kharitonov, expert at Traders Union, sees PATH trading above major moving averages, but cautions that rapid upside moves often precede profit-taking. He notes that recent insider sales by top executives may raise concerns about management’s confidence at current valuation. Kharitonov believes overbought intraday signals, such as the BBP and Stoch RSI, hint at short-term exhaustion despite positive momentum. He highlights that volatility remains elevated and warns any drop below $16.68 could accelerate downside risk. "Traders should stay vigilant here, as bullish momentum can quickly reverse if support fails to hold."

Viktoras Karapetjanc, expert at Traders Union, highlights PATH’s strong fundamental backdrop with robust revenue growth and S&P MidCap 400 inclusion. He believes the sustained bullish structure across major trend indicators keeps the outlook constructive. Karapetjanc expects further price appreciation as both annual and quarterly results beat expectations. "I see a clear path for continued gains — this market offers multiple setups for new highs if momentum persists."

Parshwa Turakhiya, analyst, observes buyers firmly in control, propelling PATH toward the top of its intraday range. He notes that high volatility and positive MACD create a fertile environment for active traders, though overbought conditions signal caution for late entries. Turakhiya analyzes the forecast band between $18.19 and $21.01 as an exciting short-term zone for scalps and momentum trades. "I would watch for quick mean-reversion plays if exhaustion sets in — opportunities may appear on both sides this week."

Upside pressure persists as intraday momentum signals risk of exhaustion

Immediate dynamic support for PATH is near the Ichimoku kijun level of $16.68, while resistance is seen at the $18.00 round level. Momentum is positive with a strong MACD buy signal and an ADX of 23.2, signaling a strengthening trend. The RSI is at 58.07 and CCI at -10.99, both neutral to slightly bullish. However, Stoch RSI and BBP highlight overbought conditions as buyers remain dominant intraday. The price opened higher, trading toward the top end of today’s $15.94 – $17.33 range, and volatility is high. While momentum and intraday strength align, some oscillators warn of potential exhaustion after this rapid upside move.

Previously it was reported that UiPath Inc. maintained a bullish trend as the price traded above key short, medium, and long-term moving averages while technical indicators such as the MACD and ADX strengthened the positive momentum despite several overbought signals. Closest support was identified around the Ichimoku Kijun and analysts expected likely consolidation between $16.50 and $18.70 amid persistent buying pressure and high volatility.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.